CYCLOALKA[b]PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVES, PROCESS FOR PRODUCING THE SAME, AND DRUGS CONTAINING THE SAME
申请人:TOA EIYO LTD.
公开号:EP0972767A1
公开(公告)日:2000-01-19
This invention relates to a cycloalka[b]pyridine-3-carbonylguanidine derivative represented by the following general formula (1) :
[wherein R1 is hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, an amino lower alkyl group, a lower alkoxyalkyl group, an aryl group, a heterocyclic group, an aralkyl group, a phenoxy lower alkyl group or an aralkyloxy lower alkyl group; R2 is hydrogen atom, a halogen atom, a lower alkoxy group or a nitro group; A is a single bond or a vinylene group; B is a vinylene or the like group; D is a single bond, a methylene group or an ethylene group; and E is a vinylene or the like group] and a salt thereof, which can provide a drug having sodium/proton (Na+/H+) exchange transport inhibitory action.
本发明涉及一种由以下通式(1)代表的环烷[b]吡啶-3-羰基胍衍生物:
[其中 R1 是氢原子、卤素原子、低级烷基、低级烷氧基、氨基低级烷基、低级烷氧基烷基、芳基、杂环基、芳烷基、苯氧基低级烷基或芳氧基低级烷基;R2 是氢原子、卤素原子、低级烷氧基或硝基;A 是单键或乙烯基;B 是乙烯基或类似基团;D 是单键、亚甲基或亚乙基;E 是乙烯基或类似基团]及其盐,可提供一种具有钠/质子(Na+/H+)交换转运抑制作用的药物。